Skye Bioscience Approves Incentive Plan Amendments and Leadership Changes
Company Announcements

Skye Bioscience Approves Incentive Plan Amendments and Leadership Changes

Skye Bioscience ( (SKYE) ) just unveiled an announcement.

Skye Bioscience, Inc. held a special meeting where stockholders approved an amendment to increase the shares available under the 2014 Omnibus Incentive Plan by 1,535,655 and extend the plan’s expiration to 2034. The plan, now named the Skye Bioscience, Inc. Amended and Restated Omnibus Incentive Plan, also increases the number of incentive stock options to 4,000,000, and was passed with 17.4 million votes in favor against 6.2 million opposed.

Learn more about SKYE stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSkye Bioscience Appoints New Chairman for Strategic Growth
TheFlySkye Bioscience names Grayson as Chairman of the Board
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App